Bank Pictet & Cie (Europe)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
900
-600
-40% -$129K ﹤0.01% 197
2026
Q1
$326K Hold
1,500
0.01% 184
2025
Q4
$343K Buy
1,500
+900
+150% +$205K 0.01% 181
2025
Q3
$139K Buy
+600
New +$122K ﹤0.01% 197

Other funds holding ABBV

Bank Pictet & Cie (Europe)'s ABBV Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $2.26M and leaving 393,597 shares worth $99M. The position accounts for 1.93% of the portfolio, ranked #12.

Bank Pictet & Cie (Europe) first reported a position in ABBV in Q4 2013 and has held it in 43 quarters since. 3,435 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 393,597 shares of AbbVie worth $99M as of Q2 2026.
  • Bank Pictet & Cie (Europe) sold 10,507 AbbVie shares in Q2 2026, an estimated $2.26M.
  • AbbVie made up 1.93% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #12 holding.
  • Bank Pictet & Cie (Europe) first reported a position in AbbVie in Q4 2013 and has held it in 43 quarters since.
  • 3,435 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.